» Articles » PMID: 18573797

FIRMA: a Method for Detection of Alternative Splicing from Exon Array Data

Overview
Journal Bioinformatics
Specialty Biology
Date 2008 Jun 25
PMID 18573797
Citations 79
Authors
Affiliations
Soon will be listed here.
Abstract

Motivation: Analyses of EST data show that alternative splicing is much more widespread than once thought. The advent of exon and tiling microarrays means that researchers now have the capacity to experimentally measure alternative splicing on a genome wide level. New methods are needed to analyze the data from these arrays.

Results: We present a method, finding isoforms using robust multichip analysis (FIRMA), for detecting differential alternative splicing in exon array data. FIRMA has been developed for Affymetrix exon arrays, but could in principle be extended to other exon arrays, tiling arrays or splice junction arrays. We have evaluated the method using simulated data, and have also applied it to two datasets: a panel of 11 human tissues and a set of 10 pairs of matched normal and tumor colon tissue. FIRMA is able to detect exons in several genes confirmed by reverse transcriptase PCR.

Availability: R code implementing our methods is contributed to the package aroma.affymetrix.

Citing Articles

Transcriptome Analysis in Mexican Adults with Acute Lymphoblastic Leukemia.

Cruz-Miranda G, Olarte-Carrillo I, Barcenas-Lopez D, Martinez-Tovar A, Ramirez-Bello J, Ramos-Penafiel C Int J Mol Sci. 2024; 25(3).

PMID: 38339034 PMC: 10855968. DOI: 10.3390/ijms25031750.


Transcriptomics for Clinical and Experimental Biology Research: Hang on a Seq.

Stokes T, Cen H, Kapranov P, Gallagher I, Pitsillides A, Volmar C Adv Genet (Hoboken). 2023; 4(2):2200024.

PMID: 37288167 PMC: 10242409. DOI: 10.1002/ggn2.202200024.


Neuronal activity regulates alternative exon usage.

Denkena J, Zaisser A, Merz B, Klinger B, Kuhl D, Bluthgen N Mol Brain. 2020; 13(1):148.

PMID: 33172478 PMC: 7656758. DOI: 10.1186/s13041-020-00685-3.


A Systems-Level Analysis Reveals Circadian Regulation of Splicing in Colorectal Cancer.

El-Athman R, Fuhr L, Relogio A EBioMedicine. 2018; 33:68-81.

PMID: 29936137 PMC: 6085510. DOI: 10.1016/j.ebiom.2018.06.012.


Integrated genomics and functional validation identifies malignant cell specific dependencies in triple negative breast cancer.

Patel N, Weekes D, Drosopoulos K, Gazinska P, Noel E, Rashid M Nat Commun. 2018; 9(1):1044.

PMID: 29535384 PMC: 5849766. DOI: 10.1038/s41467-018-03283-z.


References
1.
Stamm S, Ben-Ari S, Rafalska I, Tang Y, Zhang Z, Toiber D . Function of alternative splicing. Gene. 2005; 344:1-20. DOI: 10.1016/j.gene.2004.10.022. View

2.
Kwan T, Benovoy D, Dias C, Gurd S, Serre D, Zuzan H . Heritability of alternative splicing in the human genome. Genome Res. 2007; 17(8):1210-8. PMC: 1933514. DOI: 10.1101/gr.6281007. View

3.
Black D . Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem. 2003; 72:291-336. DOI: 10.1146/annurev.biochem.72.121801.161720. View

4.
Venables J . Aberrant and alternative splicing in cancer. Cancer Res. 2004; 64(21):7647-54. DOI: 10.1158/0008-5472.CAN-04-1910. View

5.
Maniatis T, Tasic B . Alternative pre-mRNA splicing and proteome expansion in metazoans. Nature. 2002; 418(6894):236-43. DOI: 10.1038/418236a. View